![GI_All speakers_LBA20_383O](/var/esmo/storage/images/media/esmo-daily-reporter/images/esmo-virtual-congress-2021/screenshots/gi_all-speakers_lba20_383o/9250209-1-eng-GB/gi_all-speakers_lba20_383o_i770.jpg)
Novel immunotherapy-containing strategies look promising in microsatellite stable mCRC
Immune chemo-sensitisation results show potential for this approach in the treatment of advanced CRC, but greater understanding of response characteristics is required in future clinical trials